Canada markets closed
  • S&P/TSX

    +188.74 (+0.88%)
  • S&P 500

    +40.81 (+0.80%)
  • DOW

    +90.99 (+0.23%)

    +0.0011 (+0.15%)

    +1.55 (+1.98%)
  • Bitcoin CAD

    +324.60 (+0.39%)
  • CMC Crypto 200

    0.00 (0.00%)

    +36.90 (+1.80%)
  • RUSSELL 2000

    +21.55 (+1.05%)
  • 10-Yr Bond

    -0.0720 (-1.69%)

    +183.02 (+1.14%)

    -0.29 (-2.16%)
  • FTSE

    +52.48 (+0.69%)
  • NIKKEI 225

    +744.63 (+1.90%)

    -0.0012 (-0.18%)

Materialise NV (NASDAQ:MTLS) Q3 2023 Earnings Call Transcript

Materialise NV (NASDAQ:MTLS) Q3 2023 Earnings Call Transcript October 26, 2023

Operator: Good day, and thank you for standing by. Welcome to the Q3 2023 Materialise Financial Results Conference Call. [Operator Instructions]. I would now like to hand the call over to our first speaker for today. Let me please introduce Harriet Fried of LHA.

Harriet Fried: Thank you for joining us today for Materialise's quarterly conference call. With us on the call are Fried Vancraen, Founder and Chief Executive Officer of Materialise; Peter Leys, Executive Chairman; and Koen Berges, Chief Financial Officer. Today's call and webcast are being accompanied by a slide presentation that reviews Materialise's strategic, financial and operational performance for the third quarter of 2023. To access the slides, if you've not already done so, please go to the Investor Relations section of the company's website at The earnings press release issued earlier today can also be found on that page. Before we get started, I'd like to remind you that management may make forward-looking statements regarding the company's plans, expectations and growth prospects, among other things.

These forward-looking statements are subject to known and unknown uncertainties and risks that could cause actual results to differ materially from the expectations expressed, including competitive dynamics and industry change. Any forward-looking statements, including those related to the company's future results and activities, represent management's estimates as of today and should not be relied upon as representing their estimates as of any subsequent date. Management disclaims any duty to update or revise any forward-looking statements to reflect future events or changes in expectations. A more detailed description of the risks and uncertainties and other factors that may impact the company's future business or financial results can be found in the company's most recent annual report on Form 20-F filed with the SEC.

Finally, management will discuss non-IFRS measures on today's call. A reconciliation table is contained in the earnings release and also at the end of the slide presentation. With that, I'd like to turn the call over to Peter Leys. Go ahead, please, Peter.

Peter Leys: Thank you, Harriet, and thank you, everyone, for joining us today. As always, you can find the agenda for our call on Slide #3. First, I will summarize the highlights of our financial results for the third quarter of this year. Then I will pass the floor immediately to Koen, who will go through our third quarter numbers in more detail. And after that, Fried will give you some insights on the dynamics of the changing landscape of additive manufacturing software and also on the exciting upcoming changes within our company Materialise. And finally, I will come back and explain what we believe the rest of the year will bring. When we've completed our prepared remarks, we will be happy to respond to any questions that you may have.

So let's turn to Slide 4, which summarizes the highlights of the previous quarter. In the third quarter of 2023, we recorded €60.1 million in revenues, which represents a growth of 3% compared to last year's period. And this in spite of the difficult economic circumstances. Our adjusted EBITDA for the quarter increased by 55% to €7.9 million compared to €5.1 million last year, representing an EBITDA margin of 13.1%. Our net results for the quarter amounts to €4 million or €0.07 per share. And with that, I would like to now pass the floor to Koen. Koen?

Koen Berges: Thank you, Peter. Good morning or good afternoon to all of you on this call. I'll begin with a brief review of our consolidated revenue on Slide 5. Please note that unless stated otherwise, all comparisons in this call are against our results for the third quarter of 2022. As mentioned by Peter, revenue increased 3.2% to €60.1 million. Over the past summer months, less favorable market conditions mainly impacted our manufacturing segment, which decreased by 4%, while our software segment remained stable. Our medical segment, on the other hand, continued its double-digit revenue growth and grew by 13%. Deferred revenue from software licenses and maintenance fees carried on our balance sheet amounted to €40.1 million at the end of September, representing a decrease of €2.7 million compared to the end of 2022, but still up by €1.7 million compared to September of last year.

As you can see from the graph on the right, Materialise Software accounted for 18% of our total Q2 revenue. Materialise Medical for 40% and Materialise Manufacturing for 42%. Moving on to Slide 6, you will see that our consolidated adjusted EBITDA numbers for the third quarter of 2023. The consolidated adjusted EBITDA grew to €7.9 million, representing an adjusted EBITDA margin of 13.1% compared to €5.1 million of adjusted EBITDA for the same period last year, which is an increase of almost 55%. Despite the more moderate revenue growth this quarter, we were able to significantly improve our profitability through a continued focus on scaling effects and cost control. At the same time, we continued R&D investments in our growth businesses.

Slide 7 summarizes the results of our Materialise Software segments. Software revenue remained stable at €10.8 million, while recurring revenue from maintenance contracts and renewed licenses, including CO-AM subscription fees, increased by 10%. Revenue from nonrecurring sales, on the other hand, decreased 18%, reflecting our continued transition to a recurring business model. Adjusted EBITDA for the third quarter increased significantly from €0.2 million last year to €1.8 million this year, representing an improved adjusted EBITDA margin of 16.5%. Moving on then to Slide 8. You will see that the Materialise Medical continued growing at a solid double-digit pace of more than 13%, with revenue increase coming both from medical software and from medical device solutions.

Software revenue grew by 10%, while our medical device business expanded by an aggregate of 15%. Adjusted EBITDA amounted to €7.1 million compared to €4.8 million last year, resulting in improved adjusted EBITDA margin of 29.4%. Now let's turn to Slide 9 for an overview of the Q3 performance of our Materialise Manufacturing segment. As mentioned earlier, revenue decreased 3.8% to €25.1 million, mainly due to a general slowdown in the prototyping markets. Adjusted EBITDA for the quarter dropped to €1.1 million, representing an EBITDA margin of 4.3%. More challenging market conditions impacted the segment's revenue and gross margin. On the other hand, we contained indirect costs and continued investments in our motion and eyewear business lines as planned.

Slide 10 provides the highlights of our consolidated income statement for the third quarter. Gross profit margin increased to 56% compared to 55% last year. Continued cost focus helped us to further reduce our operating expenses by €1.4 million or 4.2%. While sales and marketing and general and administrative expenses decreased, respectively, by 8% and 4%, we continued investing and increased R&D expenditures by 2%. As a result of these factors, the group's operating result was positive at €2.3 million compared to a negative €0.3 million last year. Net financial income for Q3 was positive with €1.3 million, including currency exchange gains of €4.6 million in addition to growing interest income on our cash deposits, which are more than offsetting the interest cost on outstanding loans.

Net profit for the quarter significantly increased to €4 million or €0.07 per share compared to a net profit of €1.4 million or €0.02 per share last year. Now please turn to Slide 11 for a recap of balance sheet and cash flow highlights. At the end of the third quarter of 2023, our balance sheet remains strong. Cash reserves amounted to €134 million, while our borrowings position further decreased to €66.2 million, resulting in an improved net cash position of €67.7 million. Cash flow from operating activities for the third quarter of 2023 increased to €8.1 million compared to €3.8 million last year, mainly driven by a strong EBITDA. Working capital increased only slightly over the quarter by €0.3 million. Capital expenditures for the quarter amounted to €3.9 million and included the completion of the new metal printing facility in the U.S. that we discussed in our previous earnings call as well as further investments in the new active plans.

Also this quarter, none of our capital expenditures were externally financed. And with that, I'd like to hand over to Fried.

3D Printing
3D Printing


Wilfried Vancraen: Thank you, Koen. Good morning or good afternoon to all of you listening to this call. A steady bottom line performance even in a quarter where the economic conditions of our industrial activities were unfavorable confirms the build-to-last nature of Materialise. In 1919, my wife Hilde and I founded Materialise, driven by a desire to make use of 3D printing and to make a difference with this technology. Its applications we thought could contribute to a better and healthier world. Thanks to many people around us, all over the world that started sharing the dream, we were able to build a sustainable organization called Materialise. An organization, a company that executes step-by-step on this mission of creating a better and healthier world.

We are proud of the results we achieved through relentless focus on meaningful applications of 3D printing. We are proud of the thousands and thousands of products we have improved through prototyping. And we are proud about the thousands and thousands of patients we made healthier with patient-specific instruments and implants. And the best news is that the journey we started will be continued in a sustainable way. In a build-to-last context, this means that we have to embrace change while preserving the core mission and values of Materialise. And we are in front of significant changes both in our environment in the markets that we serve and the top management structure of Materialise. Let me address both aspects. First, the market and technology fundamentals.

While I continue to believe that 3D printing is a slow revolution, the dynamic and some circumstances of the revolution are changing. For many years, the necessity of 3D printing as a manufacturing technology was questioned by money. Why would you choose 3D printing? Was a key question to answer in order to build successful operations. But today, most companies and industrial sectors are convinced about the benefits that 3D printing can bring. Their key question has shifted to how can 3D printing contribute to my success. AM materials and printing processes have proven their technical fit in a multitude of applications but still need to be scaled to economic prosperity. The how to scale is in a large extent related to the successful development of digital backbones for the business processes and the user companies in general and for AM production lines in particular.

Is there that the scalability of 3D printing currently hits another roadblock? In the '90s and the early 2000s, the remarkable partnership between Intel and Microsoft, often referred to as Wintel, played a pivotal role in propelling the computer industry to new heights. It provided a standard platform for hardware and software. Wintel established a stable and harmonious ecosystem. And despite occasional concerns regarding competition, this interoperability led to rapid search in software development in an expansive range of applications. It helped a robust user experience ushering [indiscernible] fast forward today, and we see [indiscernible]. It's by a myriad of platforms, interfaces, operating systems, cloud computing providers, IoT devices and more.

This diversity offers users a wealth of options and flexibility, but it also introduces complexity and escalated costs. In the context of 3D printing and inherently digital technology, this complexity can be particularly problematic. The companies in the 3D printing industry must commit resources to ensure that our printers and accompanying softwares are compatible with an array of devices, operating systems and file formats. This does not only cost to incur costs, but also divest resources that could otherwise be channeled into innovation and growth. And as such, this complexity may hinder growth of the 3D printing industry where interoperability and compatibility are paramount. And as a consequence, the advent of distributed manufacturing is delayed.

With our heavy investment in CO-AM, our digital manufacturing platform, Materialise has risen to meet these challenges. Offering manufacturers an open software platform to manage, scale and standardize their production workflows across integrated supply chains and diverse IT environments. The verticals of Materialise, the medical segment in particular, demonstrate our good digital backbone from patient data over surgical planning to automate the design using advanced IT tools in a global context enables to scale AM economically. We demonstrate it can happen personalized with respect for patient privacy in the cloud also in tune with the legal requirements of many different countries. I believe the slow AM revolution will continue, and Materialise will continue to play a rating role in that revolution under the guidance of our new CEO, Brigitte de Vet.

Brigitte joined Materialise in 2016 with many years of experience in companies like Johnson & Johnson and Acertys already under her belt. She took over the general management of the Materialise Medical segment from me at that time. Over her tenure at the helm of Materialise Medical, she has grown this segment to become the most profitable of all the company segments today. We are confident that under her leadership, Materialise will continue its track as a built-to-last company. Brigitte will provide continuity as over the last 7 years she delivered ample proof that you could guide her management team in delivering value to patients and all other stakeholders in the medical device companies and hospitals. In addition, during all those years, she was an active member of the executive committee that she will lead from the 1st of January 2024 onwards.

In the executive committee, she will be able to rely on the stable team that has been in the operational leadership of Materialise for many years. We strongly believe that Brigitte and her executive committee will continue to bring innovative solutions to the Materialise customer base. She will as well provide an inspiring work environment that fosters personal growth to the employees. Peter, Hilde and I have been preparing in coordination with the Board for the current transition. We are convinced that the new but highly experienced executive committee will be well placed to deliver value to the shareholders. Peter, Hilde and I will also remain closely connected to the strategic positioning of Materialise as nonexecutive members of its Board where I will take over the presidency from Peter Leys.

And I want to take this opportunity to thank Peter for his formidable contributions to Materialise. It is thanks to Peter that Materialise was able to enter the U.S. stock market and that we have been able to fulfill all the legal requirements consistently. Our presence on the stock market has been an integral part of our strategy to operate as an independent platform and solutions provided in the many different markets that additive manufacturing can serve. But Peter's contributions go much further. He has been instrumental to the performance of Materialise, keeping the balance between a healthy financial performance and the diligence in execution of projects that contribute to our mission. I believe that all of you who regularly participate in these quarterly calls has appreciated the forthright, but also humorous communication that has become a trademark for Materialise in its Investor Relations.

And I will certainly count on its continued input as I take over the presidency of the Board. As Board members, Hilde and I will keep traveling the world in support of Materialise in the years to come, representing the company at major sales and industry in advance. We remain committed to the value that Materialise will bring as a build-to-last company to society and look forward to seeing some of you in just a few days at Formnext. Then we will have the opportunity to discuss the future in more detail. And let me now pass the call back to Peter.

Peter Leys: Thank you. Thank you so much, Fried. Currently, with respect to our financial outlook, we continue to expect our full year revenues to be between €255 million and €260 million. And this in spite of the more challenging macroeconomic conditions that we are in. When we reported our first quarter results in April, we increased, as you may remember, the expected range of our adjusted EBITDA for 2023 by 10% to an amount between €28 million and €33 million. Today, we are maintaining that increased EBITDA guidance. This concludes our prepared remarks. This actually also concludes my active participation in the quarterly calls with the investor community. I would like to thank everybody on the other side of the call for the constructive relationship that we have built over the last decade.

It has been a pleasure and an honor to engage in dialogues with you about one of my and hopefully, also your favorite topics, the execution of the mission and vision of Materialise. Together with Fried and Hilde, I will continue to serve Materialise and to support Brigitte and the entire executive management team as a member of the Board. I have full confidence that in this new constellation, Materialise remains in good, safe and innovative hands. And with that, operator, I would like to open the call to questions.

See also 25 Dumbest States in America and Top 30 Cities in the World with Most Millionaires.

To continue reading the Q&A session, please click here.